Ocular Therapeutix OCUL Sales & Marketing
Sales & Marketing at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's sales & marketing?
- Ocular Therapeutix (OCUL) reported sales & marketing of $16.58M in Q1 2026.
- How has Ocular Therapeutix's sales & marketing changed year-over-year?
- Ocular Therapeutix's sales & marketing increased by 17.2% year-over-year, from $14.15M to $16.58M.
- What is the long-term trend for Ocular Therapeutix's sales & marketing?
- Over 4 years (2021 to 2025), Ocular Therapeutix's sales & marketing has grown at a 11.3% compound annual growth rate (CAGR), from $35.19M to $53.92M.
- What does sales & marketing mean?
- Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.